Investment company with registered office in Zurich ( Switzerland ) is looking to acquire
a significant percentage of the capital of start-up or scale-up companies in the sector of
slowing down human ageing processes.
Please direct your contact to the attention of : Dr. P. Keller

US Merchant Bank is conducting a search on behalf of a major international e-commerce group with an eye to buying a majority stake in one or more companies that own licensed online pharmacies, operating in any country.
Please note that there are no maximum limits on the size of the business.

The utmost confidentiality is guaranteed.

Globally active firm producing and distributing reagents for in-vitro molecular diagnostic testing seeks to acquire a controlling share in a company with successful operations in the development and production of biotechnologies and innovative solutions for modern clinical diagnostic needs.
Following the initial contact request, the applicant company will be asked to prepare a detailed information memorandum in English.

MA global consultancy working on behalf of a well-known private equality firm is looking to purchase a majority share in a company active in producing pharmaceuticals and plasma derivatives for treating unusual and rare pathologies.
Aside from any agreements currently in place between the target company and relevant healthcare authorities, the buyer specifically requests high industrial quality and safety standards. The existence of a suitable technological research and innovation center would also be highly appreciated.
Any potential contact will be handled with the utmost professional discretion.

We are a team of French researchers that grew out of a university spin-off holding several patents in the field of molecular medicine. We have recently identified and isolated a gene that inhibits sensitivity to chemotherapy treatments of the intestinal tract; taking advantage of therapeutic magnetic nanoparticles, we have developed a diagnostic kit using this technology.
In order to enhance the value of this scientific finding, we are interested in productive engagement with a venture capitalist specialized in this field with an eye to collaboratively evaluating the best prospects for economic development.